Who we are

QUODEM - Marketing and Information Technology Services

QUODEM is a company which focuses its activities on offering solutions for marketing and the development of business based on information technologies.

There are two basic lines of business on which QUODEM concentrates its activities:

• The Health Line. Intended to maximise the strategies of the agents of the health sector through the use of information technologies.

• The Consultancy Line. Intended for companies of different sectors which need to introduce or increase their presence within the online channels.

News

· Quodem opens new office in Lisbon.

[18/03/2011]

· The PneumoPDA Project (a Pneumology handbook developed for PDAs by QUODEM) is launched at the NeumoSur Congress.

[18/03/2010]

· QUODEM designs and develops the product handbook (multimedia and print) for the launch of IRESSA (AstraZeneca).

[5/03/2010]

· QUODEM integrates its online learning, accreditation and tests platform in Univadis.es (MSD).

[01/03/2010]

Articles

· "Design, usability and accessibility; the user’s revolution"

[More]

· "The information technologies and the improvements in the compliance with the prescription"

[More]

· "On-line Training of the Sales Force "

[More]

Products

Entrenamiento de Fuerza de Ventas eFdV
The most complete Training Platform for a Sales Force on the market. [More]

NEXO, sesiones interactivas NEXO
With our Multimedia System for Attending Training Courses, it is possible to optimise your courses and presentations. [More]

Interviews Icono de Entrevista

Fernando Martínez Quintana

Training Manager
AstraZeneca
SPAIN

What do you think is the influence of the “new technologies” on the internal formation of the pharmaceutical industry?

The use of the new technologies in the training and formation of the Commercial Networks of any sector plays an absolutely crucial role. Thanks to these technologies, the proper training can reach each Delegate in a fast and effective manner, allowing for the implementation of ambitious plans for continuous training...

[More]

Other published interviews:

Dr. Carlos
Melero Moreno
H. 12 Octubre

Fernando
Martínez
Quintana
AstraZeneca